Latest Regulatory News

Critical Minerals Group (CMG) has secured a $2.7 million federal grant to fast-track its vanadium electrolyte manufacturing facility in Queensland, alongside key project milestones and strategic leadership appointments.

Starpharma reports encouraging FDA feedback on its DEP® SN38 candidate for ovarian cancer and prepares for product launches in Saudi Arabia and UAE, supported by a solid $20.3 million cash position.

Austral Resources Australia Ltd reports steady operational progress and promising resource developments in its December 2024 quarter, while navigating an ongoing recapitalisation and leadership transition.

PVW Resources has appointed Lucas Stanfield as CEO, bringing rare earths project expertise to accelerate development of its Brazilian assets. Stanfield’s leadership marks a strategic pivot towards advancing critical mineral projects in a globally significant mining jurisdiction.

ReNerve Limited has reported a remarkable 260% increase in quarterly sales following its successful IPO, alongside strategic distribution deals in Hong Kong and the Middle East. The company is poised for further growth with upcoming clinical data and product developments.

Global Lithium Resources Limited has formally requested a review of a recent Takeovers Panel ruling, signaling ongoing regulatory scrutiny that could influence its corporate trajectory.

Jupiter Energy Limited reported steady oil sales revenue of approximately US$1.76 million for Q4 2024, driven entirely by domestic channels, alongside commissioning a key gas utilisation project and launching a $4 million capital raise.

Artrya Limited reports solid progress on its FDA 510(k) application and secures a A$5 million capital raise, positioning itself for imminent commercial rollout in the US healthcare sector.

Skylark Minerals has reshaped its leadership team with seasoned gold industry veterans and agreed to divest its Citronen Zn-Pb Project, positioning the company for renewed growth and exploration success.

Brazilian Rare Earths Limited reports unprecedented ultra-high-grade rare earth intercepts and significant district-scale mineral discoveries at its Monte Alto project, alongside key permitting milestones advancing its mining ambitions.

Global Lithium Resources pauses Definitive Feasibility Study on its flagship Manna Lithium Project due to challenging lithium markets, while advancing strategic acquisitions and exploration in Western Australia.

Neurotech International reports key clinical progress in paediatric neurological disorders, securing FDA orphan drug designation for its Rett Syndrome treatment and advancing pivotal trials for ASD and PANDAS/PANS.